Notable Labs Corp (NTBL): Sotuvga nisbatan narx
Notable Labs, Ltd. (NTBL) tirik hujayralarda terapiya samaradorligini tahlil qilish uchun ilg'or PPMP IT tizimini ishlab chiqmoqda. Ushbu metod ideal davolash usulini aniqlash uchun minglab dori vositalarining funksional diagnostikasiga asoslangan. Median P/S ko'rsatkichi biznes qiymatini daromadga nisbatan baholashga yordam beradi, bunda 7.70 ushbu parametrning miqdorini aks ettiradi. Jarayon laboratoriya tadqiqotlarining aniqligini ta'minlovchi optimallashtirilgan ekspress bio-namuna transport tarmog'i bilan yakunlanadi.
Notable Labs Inc. (NTBL) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va konsensus maqsadli narx:
- birja kapitallashuvi ma'lumotlari:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning xususiy kapitalga nisbati Notable Labs, Ltd.|NTBL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Notable Labs Corp|NTBL - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Notable Labs Inc.|NTBL - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Notable Labs|Tezkor likvidlik notablelabs.com
- foyda va bozor koeffitsiyentlari statistikasi:
NTBL - Sof foyda|Prognoz qilingan kelajakdagi foyda Notable Labs, Ltd.|NTBL - P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Notable Labs Ltd|NTBL - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Notable Labs Inc.|NTBL - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Notable Labs|NTBL - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi notablelabs.com|NTBL - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Notable Labs, Ltd.
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:NTBL - notablelabs.com
Notable Labs, Ltd. (NTBL) kompaniyasining makroiqtisodiy sikllardan mustaqilligi va medtech innovatsiyalariga bo'lgan barqaror talab joriy P/S koeffitsiyentini kompaniyaning kapitalga intensiv biznes rivojlanishiga bo'lgan bozor ishonchining asosiy ko'rsatkichi qiladi. Ushbu metrika kompaniyaning qiymatini uning daromadiga nisbatan aks ettirib, investorlarga sotuvlarning har bir dollari uchun to'langan premiumni baholash va kotirovkalarning haqiqiy operatsion daromadga nisbatan qanchalik hadda qimmat baholanganini aniqlash imkonini beradi.
Notable Labs, Ltd. kimlar bilan raqobatlashadi
beigene.com - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati Halozyme HALO|Revolution Medicines Inc (RVMD) - Sotuvga nisbatan narx|AAPG: Kapitalizatsiyaning daromadga nisbati|CG Oncology Therapeutics - Kapitalizatsiyaning sotish hajmiga nisbati|URGN: P/S multiplikatori|bicara.com (BCAX) - P/S multiplikatori|PSNL (Personalis) - P/S multiplikatori|Narxning daromadga nisbati ERAS|Narxning daromadga nisbati Delcath (DCTH)|Narxning daromadga nisbati YMAB (Y-mAbs Corp)|P/S multiplikatori AURA (Aura Biosciences, Inc.)|Candel Therapeutics Inc. (CADL) - Sotuvga nisbatan narx|ARAY: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati SLS (SELLAS Life Sciences)|Actuate Therapeutics, Inc (ACTU) - Narxning daromadga nisbati|CTOR (Citius Oncology Inc) - Narxning daromadga nisbati|HURA (TuHURA Biosciences Inc.) - P/S multiplikatori|P/S multiplikatori protaratx.com|P/S multiplikatori FATE|Narxning daromadga nisbati WHWK (aadibio.com)|Narxning daromadga nisbati TScan Therapeutics, Inc. TCRX|Narx/daromad koeffitsiyenti Champions Oncology Inc (CSBR)|XBIT: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati CVM (CEL-SCI Corporation)|OS Therapies (OSTX) - Narxning daromadga nisbati|RADX (radiopharmtheranostics.com) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati ARTV|ANL (Adlai Nortye Limited) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori VERU|tempesttx.com - Kapitalizatsiya va daromad nisbati|Xilio Therapeutics - Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Renovaro Biosciences (RENB)|MURA - Narxning daromadga nisbati|KAPA (Kairos Pharma Ltd) - Kapitalizatsiya va daromad nisbati|OKUR (onkuretherapeutics.com) - Kapitalizatsiyaning daromadga nisbati|GDTC: Kapitalizatsiyaning sotish hajmiga nisbati|CRIS (Curis Inc.) - P/S multiplikatori|Narxning daromadga nisbati APLM|Narxning daromadga nisbati Tharimmune Corp (THAR)|Narxning daromadga nisbati ADVB (advanbiomed.com)|P/S multiplikatori GNPX (Genprex, Inc.)|CLDI - Kapitalizatsiyaning daromadga nisbati|Sunshine Biopharma, Inc. - P/S multiplikatori|XBIO - P/S multiplikatori|Salarius (SLRX) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati PPBT|AONC (American Oncology Network Inc) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati beigene.com (BGNE)|P/S multiplikatori CKPT|ELEV - Sotuvga nisbatan narx|Narxning daromadga nisbati iCAD ICAD|Bozor kapitallashuvining daromadga nisbati IKNA|VIRX: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati MOR (morphosys.com)|NAYA: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Ascentage Pharma Group International
